The pathological contribution of IGF2BP2 in NAFLD was speculated to be through monocyte chemoattractant protein-1 (MCP-1) [101] which is associated with NASH [101] and HCC [114]. The gene discussed is IGF2BP2; the disease is metabolic dysfunction-associated steatotic liver disease.